Scholarship. Antibiotice Iasi shares, which last year delivered a return of 83% to investors, have a minus of 17% since the beginning of 2025. Why?

The shares of Antibiotice Iaşi (ATB), a company controlled by the Romanian State through the Ministry of Health with 53% and which last year was the best performer on the Stock Exchange, registered a decrease of approximately 16% from the beginning of 2025 in the context of some profit marks after significant increases in the last two years and against the background of financial results that did not meet investors' expectations Brokers say.